A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
Antibody responses to SARS-CoV-2 may be important biomarkers for assessing the risk for viral transmission. Here the authors present serological antibody profiling results of COVID-19 patients using a new multiplex assay to show distinct kinetics and dynamics of IgG, IgM and IgA responses in patient...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49ad9d0b0b924b0ea4951e73d801de03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:49ad9d0b0b924b0ea4951e73d801de03 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:49ad9d0b0b924b0ea4951e73d801de032021-12-02T10:44:18ZA multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients10.1038/s41467-021-21040-72041-1723https://doaj.org/article/49ad9d0b0b924b0ea4951e73d801de032021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21040-7https://doaj.org/toc/2041-1723Antibody responses to SARS-CoV-2 may be important biomarkers for assessing the risk for viral transmission. Here the authors present serological antibody profiling results of COVID-19 patients using a new multiplex assay to show distinct kinetics and dynamics of IgG, IgM and IgA responses in patients with different disease severity.Allison N. GrossbergLilia A. KozaAurélie LedreuxChad PrusmackHari Krishnan KrishnamurthyVasanth JayaramanAnn-Charlotte GranholmDaniel A. LinsemanNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Allison N. Grossberg Lilia A. Koza Aurélie Ledreux Chad Prusmack Hari Krishnan Krishnamurthy Vasanth Jayaraman Ann-Charlotte Granholm Daniel A. Linseman A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients |
description |
Antibody responses to SARS-CoV-2 may be important biomarkers for assessing the risk for viral transmission. Here the authors present serological antibody profiling results of COVID-19 patients using a new multiplex assay to show distinct kinetics and dynamics of IgG, IgM and IgA responses in patients with different disease severity. |
format |
article |
author |
Allison N. Grossberg Lilia A. Koza Aurélie Ledreux Chad Prusmack Hari Krishnan Krishnamurthy Vasanth Jayaraman Ann-Charlotte Granholm Daniel A. Linseman |
author_facet |
Allison N. Grossberg Lilia A. Koza Aurélie Ledreux Chad Prusmack Hari Krishnan Krishnamurthy Vasanth Jayaraman Ann-Charlotte Granholm Daniel A. Linseman |
author_sort |
Allison N. Grossberg |
title |
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients |
title_short |
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients |
title_full |
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients |
title_fullStr |
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients |
title_full_unstemmed |
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients |
title_sort |
multiplex chemiluminescent immunoassay for serological profiling of covid-19-positive symptomatic and asymptomatic patients |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/49ad9d0b0b924b0ea4951e73d801de03 |
work_keys_str_mv |
AT allisonngrossberg amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT liliaakoza amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT aurelieledreux amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT chadprusmack amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT harikrishnankrishnamurthy amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT vasanthjayaraman amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT anncharlottegranholm amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT danielalinseman amultiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT allisonngrossberg multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT liliaakoza multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT aurelieledreux multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT chadprusmack multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT harikrishnankrishnamurthy multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT vasanthjayaraman multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT anncharlottegranholm multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients AT danielalinseman multiplexchemiluminescentimmunoassayforserologicalprofilingofcovid19positivesymptomaticandasymptomaticpatients |
_version_ |
1718396760084185088 |